1/3
Export Ready

GEMDRONIC 5MG

Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Price
Price on request
In stock
Inclusive of all taxes
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HS Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Values shown are for melizza lifescience.
Compliance & Certifications
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

melizza lifescience is a Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup based in Rajkot Gujarat India.

Rajkot Dispatch on request Verified seller
melizza lifescience logo

melizza lifescience

Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
Not shared
Employees
–
GST
24GQFPM5460R1Z4
IEC code
GQFPM5460R
Export markets
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
GlobalLinker Member Since
Aug 2025
Turnover
Incorporation Type
On request
Verified Seller
Product details

What are the specifications of this product?

Overview

Product Name: Gemdronic 5mg Injection Generic Name: Zoledronic Acid 5 mg/100 mL Manufacturer: (Marketed under various oncology/critical care brands; “Gemdronic” is one such brand) Therapeutic Category: Oncology / Bone Health (Bisphosphonate) Product Description: Gemdronic Injection contains Zoledronic Acid, a potent bisphosphonate that inhibits bone resorption. It is commonly used to treat hypercalcemia of malignancy, bone metastases, multiple myeloma, and osteoporosis. By blocking osteoclast-mediated bone breakdown, Zoledronic Acid strengthens bone, reduces skeletal complications, and helps lower elevated blood calcium levels caused by cancers. Indications: • Hypercalcemia of malignancy (tumor-induced high calcium levels) • Bone metastases from solid tumors • Multiple myeloma (skeletal-related events prevention) • Osteoporosis (postmenopausal, glucocorticoid-induced, male osteoporosis) • Paget’s disease of bone Mechanism of Action: • Zoledronic Acid binds to bone mineral and inhibits osteoclast activity, reducing bone resorption. • Decreases release of calcium from bone, preventing skeletal complications.

Product Description

Dosage & Administration:

• Administered as intravenous infusion only.

• 5 mg once yearly (for osteoporosis).

• 4 mg every 3–4 weeks (for oncology indications such as bone metastases).

• Dose and frequency depend on indication and patient’s renal function.

(Must be given by a healthcare professional under strict supervision.)


Key Benefits:

• Reduces risk of fractures and bone complications in cancer patients.

• Long-lasting bone protection with infrequent dosing.

• Effective in lowering high calcium levels caused by tumors.


Packaging:

• Single-dose vial: 100 mL solution containing 5 mg Zoledronic Acid.


Storage:

• Store below 30°C.

• Do not freeze.

• Protect from light.


Important Notes:

• For hospital/oncology use only.

• Not recommended in patients with severe kidney impairment.

• Adequate hydration before and after infusion is essential.

• Calcium and vitamin D supplementation may be required during treatment.


ONCOLOGY SUPPLIER

Melizza Lifescience

Description provided by melizza lifescience.

Specifications

Generic Name Zoledronic Acid
Brand Name Gemdronic 5mg
Concentration 5 mg/100 mL
Formulation Type Sterile injectable solution
Therapeutic Category Bisphosphonate for Oncology and Bone Disorders
Route of Administration Intravenous infusion
Shelf Life Refer to product packaging/manufacturer guidelines
Manufacturer Marketed under various oncology and critical care brands
Usage Restrictions For hospital/oncology use only
Precautions Monitor renal function; ensure adequate hydration; vitamin D and calcium supplementation recommended

Use cases

Category Pharmaceuticals > Oncological Drugs > Bone Modifying Agents > Bisphosphonates
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing GEMDRONIC 5MG. Answers compiled from verified sellers' commercial terms and platform data.

Q: Can Gemdronic 5mg be used in patients with severe renal impairment?
A: Gemdronic 5mg is not recommended for patients with severe kidney impairment due to the risk of adverse effects; renal function must be assessed before administration.
Q: What is the recommended frequency of Gemdronic 5mg administration for osteoporosis?
A: For osteoporosis, Gemdronic 5mg is typically administered as a 5 mg intravenous infusion once yearly under medical supervision.
Q: How does Gemdronic 5mg help in managing bone metastases in cancer patients?
A: Gemdronic 5mg inhibits osteoclast-mediated bone resorption, reducing skeletal complications such as fractures and lowering elevated calcium levels caused by bone metastases.
Q: Are calcium and vitamin D supplementation necessary during treatment with Gemdronic 5mg?
A: Yes, calcium and vitamin D supplementation are often recommended to support bone health and reduce the risk of hypocalcemia during treatment.
Q: Is Gemdronic 5mg suitable for outpatient treatment or restricted to hospital use?
A: Gemdronic 5mg is intended for hospital or oncology center use only and must be administered by healthcare professionals through intravenous infusion.
Question not answered? Ask sellers directly — typical response within 4 hours.

What similar products are available in this category?

Browse all in category
View all →
remtrex 2.5mg, 15mg,
remtrex 2.5mg, 15mg,
USD 0.00 MOQ 1 Centimetre
View Product
erlocip 150mg
erlocip 150mg
USD 0.00 MOQ 1 Centimetre
View Product
gemdronic 5mg
gemdronic 5mg
USD 0.00 MOQ 1 Centimetre
View Product
altanib nova imatinib 400mg tablets
altanib nova imatinib 400mg tablets
USD 0.00 MOQ 1 Centimetre
View Product
lucrin depot 3.75 mg / 11.25 mg injection
lucrin depot 3.75 mg / 11.25 mg injection
USD 0.00 MOQ 1 Centimetre
View Product
truvada-tablets
truvada-tablets
USD 0.00 MOQ 1 Centimetre
View Product
abstet 250mg tablet (abiraterone acetate (250mg))
abstet 250mg tablet (abiraterone acetate (250mg))
USD 0.00 MOQ 1 Piece
View Product
syringe glycerine
syringe glycerine
USD 0.00 MOQ 1 Centimetre
View Product
GEMDRONIC 5MG
GEMDRONIC 5MG
Price on request · MOQ 1Centimetre